Ichidai Tanaka - Concepedia

Author

Ichidai Tanaka

Nagoya University ORCID

Also Known As

I Tanaka, I. Tanaka, Ibuki Tanaka, Ichidai Tanaka, Ichidai Tanaka. Ichidai Tanaka, Tanaka, Ichidai, 田中一徹

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Nagoya University Aichi Cancer Center The University of Texas MD Anderson Cancer Center Fujita Health University The University of Texas Southwestern Medical Center

About

Ichidai Tanaka is an author at Nagoya University specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	499
2	Cell Biology	4	4	475
3	Immunology	2	2	100
4	Engineering	1	1	17
5	Cellular Physiology	1	1	17

Ichidai Tanaka

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes Tetsuya Mizuno, Hideki Murakami, Makiko Fujii, Oncogene Tumor BiologyCell RegulationMalignant DiseaseTumor SuppressorCell Cycle-promoting Genes	2012	279
Role of CPS1 in Cell Growth, Metabolism, and Prognosis in LKB1-Inactivated Lung Adenocarcinoma Müge Çeliktaş, Ichidai Tanaka, S. C. Tripathi, JNCI Journal of the National Cancer Institute	2016	106
Loss of <i><scp>YAP</scp>1</i> defines neuroendocrine differentiation of lung tumors Takeshi Ito, Daisuke Matsubara, Ichidai Tanaka, Cancer Science	2016	105
Regulation of PD-L1 expression by matrix stiffness in lung cancer cells Ayako Miyazawa, Satoru Ito, Shuichi Asano, Biochemical and Biophysical Research Communications Pd-l1 ExpressionMedicineMatrix StiffnessCell-matrix InteractionCell Biology	2017	103
SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1–Negative Lung Adenocarcinomas Ichidai Tanaka, Delphine Daydé, Mei-Chee Tai, JNCI Journal of the National Cancer Institute	2021	78
Plasma-derived extracellular vesicle proteins as a source of biomarkers for lung adenocarcinoma Jody V. Vykoukal, Nan Sun, Clemente Aguilar-Bonavides, Oncotarget	2017	77
LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade Ichidai Tanaka, Hiroyuki Osada, Makiko Fujii, Oncogene Signaling PathwayMalignant DiseaseImmunologyLim-domain Protein AjubaTumor Suppressor	2013	76
Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma: TGFβ signaling and defects in the Hippo signaling cascade Makiko Fujii, Hayao Nakanishi, Takeshi Toyoda, Cell Cycle	2012	51
Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis Soei Gen, Ichidai Tanaka, Masahiro Morise, BMC Cancer	2022	43
Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma Johannes F. Fahrmann, Ichidai Tanaka, Ehsan Irajizad, Cancers	2022	37

Page 1